Advanced Medical Solutions Rating Reiterated by N+1 Singer (AMS)
Advanced Medical Solutions (LON:AMS)‘s stock had its “sell” rating reiterated by N+1 Singer in a research note issued on Wednesday, American Banking and Market News reports. They currently have a GBX 84 ($1.31) price target on the stock. N+1 Singer’s target price would suggest a potential downside of 7.69% from the stock’s previous close.
Shares of Advanced Medical Solutions (LON:AMS) opened at 90.493 on Wednesday. Advanced Medical Solutions has a 52 week low of GBX 54.00 and a 52 week high of GBX 93.00. The stock has a 50-day moving average of GBX 83.95 and a 200-day moving average of GBX 77.74.
AMS has been the subject of a number of other recent research reports. Analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Advanced Medical Solutions (LON:AMS) in a research note to investors on Wednesday. They now have a GBX 84 ($1.31) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Advanced Medical Solutions (LON:AMS) in a research note to investors on Tuesday, September 3rd. They now have a GBX 90 ($1.41) price target on the stock.
One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. Advanced Medical Solutions currently has a consensus rating of “Hold” and an average target price of GBX 83.20 ($1.30).
Advanced Medical Solutions Group plc is involved in the design, development, licensing, manufacture and distribution of polymers (LON:AMS) for use in advanced woundcare dressings and materials, and medical adhesives, for closing and sealing tissue.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.